This is the authors' abstract. We don't add key points for this paper.
The field of stem cell therapy is growing rapidly and hopes to offer an alternative solution to diseases that are historically treated medically or surgically. One such focus of research is the treatment of medically refractory epilepsy, which is traditionally approached from a surgical or interventional standpoint. Research shows that stem cell transplantation has potential to offer significant benefits to the epilepsy patient by reducing seizure frequency, intensity, and neurological deficits that often result from the condition. This review explores the basic science progress made on the topic of stem cells and epilepsy by focusing on experiments using animal models and highlighting the most recent developments from the last 4 years.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Alayli et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: